Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Blood cancers, Low grade lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)
Closed
Phase 3
This trial is looking at bendamustine with or without ofatumumab for non Hodgkin lymphoma affecting cells called B cells. The people taking part have low grade lymphoma and have already had treatment with rituximab.
Recruitment start: 7 September 2010
Recruitment end: 16 May 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Simon Rule
Experimental Cancer Medicine Centre (ECMC)
GlaxoSmithKline (GSK)
NIHR Clinical Research Network: Cancer
Last reviewed: 29 Aug 2016
CRUK internal database number: 8235